(Q72526381)
Statements
Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach? (English)
V Borgmann
W Hardt
M Schmidt-Gollwitzer
H Adenauer